MedPage Today on MSN
Kate Middleton's Chemo; SGLT2 Inhibitors and Prostate Cancer; New Myeloma Guidance
The novel MEK inhibitor atebimetinib in combination with modified gemcitabine/nab-paclitaxel led to a 12-month overall ...
A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
1don MSN
Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.
Probiotics and broccoli could help to slow the spread of prostate cancer, research suggests. Broccoli, turmeric, pomegranate, ...
Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...
Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or ...
A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed.Many men ...
News-Medical.Net on MSN
New trial aims to improve both survival and quality of life for men with advanced prostate cancer
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
2don MSN
An electronic health record-integrated AI agent advances personalized prostate cancer education
Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large ...
WHNT-TV Huntsville on MSN
Prostate cancer survivors speak on push for new screening legislation | Jan. 9, 2026 | News 19 at 6 p.m.
Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results